Evidence map›Paper›PMID 40487443›Full record

ArticleiScience2025

Bronchial smooth muscle extracellular vesicles interfere with bronchial epithelium metabolism and function in asthma.

Elisa Celle, Amine Chahin, Fabien Beaufils, Guillaume Cardouat, Edmée Eyraud, Clément Bouchet, Marilyne Campagnac, Olga Ousova, Hugues Begueret, Matthieu Thumerel and 11 more

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Elisa CelleUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Amine ChahinUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Fabien BeaufilsUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Guillaume CardouatUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Edmée EyraudUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Clément BouchetUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Marilyne CampagnacUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Olga OusovaUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Hugues BegueretCHU de Bordeaux, Service d'exploration fonctionnelle respiratoire, Service de pharmacologie, CIC 1401, Service de chirurgie thoracique, 33604 Pessac, France.
Matthieu ThumerelUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Rémi DuboisUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Jean-William DupuyUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Thierry Leste-LasserreUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Sabrina LacommeUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Nina Lager-LachaudUniversité de Toulouse, CNRS 5504, INRA 792, INSA Toulouse, Toulouse Biotechnology Institute, Bio & Chemical Engineering, MetaToul, Toulouse, France.
Floriant BellvertUniversité de Toulouse, CNRS 5504, INRA 792, INSA Toulouse, Toulouse Biotechnology Institute, Bio & Chemical Engineering, MetaToul, Toulouse, France.
Roger MarthanUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Pierre-Olivier GirodetUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Patrick BergerUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Thomas TrianUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.
Pauline EstevesUniv-Bordeaux, Centre de Recherche Cardio-thoracique de Bordeaux, U1045, Département de Pharmacologie, Bordeaux Proteome, TBM-Core, US5, UAR 3427, OncoProt, CIC 1401, 33000 Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bronchial smooth muscle (BSM) remodeling is an important feature of severe asthma pathophysiology. We previously showed that asthmatic BSM is metabolically different and increased rhinovirus (RV) replication rate, the main trigger of severe asthma exacerbations. Extracellular vesicles (EVs) are the key mediator in cell-cell communication, but the role of BSM cells-derived EVs on bronchial epithelial has never been investigated in asthma. Using severe asthmatic and non-asthmatic tissue collection, we show that asthmatic BSM cells are able to produce a greater amount of EVs containing metabolites involved in bioenergetics. We study the bronchial epithelium energetic rewiring following stimulation with asthmatic BSM cells-derived EVs. Modifications of bronchial epithelium metabolic behavior were associated with an increased ATP production and a breakdown of bronchial epithelium barrier function such as ciliary beating frequency and efficiency. Finally, we show that asthmatic BSM cells-derived EVs increased RV replication in bronchial epithelium following RV infection.

Indexed as

Cell biologyPathology

Identifiers

PMID40487443
PMCPMC12141081

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.